Literature DB >> 15228495

Tuberculosis control in resource-poor countries: have we reached the limits of the universal paradigm?

Christian Lienhardt1, Jessica Ann Ogden.   

Abstract

The aim of TB control is to break the cycle of transmission by treating TB cases as early and efficiently as possible. In its efforts to promote a model of worldwide TB control, WHO defined specific targets and launched the 'Directly Observed Therapy, Short-course' (DOTS) strategy as the main tool to reach them. However, the diversity of patients' attitudes towards the disease and the extreme variability of access to care, especially in resource-poor countries, are amongst the many factors of social context that profoundly affect the ability of control programmes to implement this policy effectively. There are multiple reports of TB control programmes using various types of intervention to promote adherence and enhance case-holding, but most of these interventions depend on external funding, which bring into question their long-term sustainability. In this paper, we address the problems related to operational variabilities in the implementation of the DOTS strategy in resource-poor countries and question the appropriateness of a universal paradigm for global TB control. This analysis is of particular importance as programmers consider using this model in the delivery of anti-retroviral therapies for the treatment of HIV in resource-limited settings. Copyright 2004 Blackwell Publishing Ltd

Entities:  

Mesh:

Year:  2004        PMID: 15228495     DOI: 10.1111/j.1365-3156.2004.01273.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  30 in total

1.  Frustrations with FIDELIS: promising idea, problematic approach.

Authors:  Krista Jane Lauer; Anne-Emanuelle Birn
Journal:  Am J Public Health       Date:  2006-07-27       Impact factor: 9.308

2.  Children's roles in tuberculosis treatment regimes: constructing childhood and kinship in urban Zambia.

Authors:  Jean Hunleth
Journal:  Med Anthropol Q       Date:  2013-06-26

3.  Surveillance or support: The experience of direct observation during tuberculosis treatment.

Authors:  Ietza Bojorquez; Irais Salazar; Richard S Garfein; Paris Cerecer; Timothy C Rodwell
Journal:  Glob Public Health       Date:  2016-10-16

4.  Socio-demographic determinants of stigma among patients with pulmonary tuberculosis in Lagos, Nigeria.

Authors:  I A Abioye; M O Omotayo; W Alakija
Journal:  Afr Health Sci       Date:  2011-08       Impact factor: 0.927

5.  Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients.

Authors:  Justin J Wilkins; Grant Langdon; Helen McIlleron; Goonaseelan Pillai; Peter J Smith; Ulrika S H Simonsson
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

6.  What 'outliers' tell us about missed opportunities for tuberculosis control: a cross-sectional study of patients in Mumbai, India.

Authors:  Anagha Pradhan; Karina Kielmann; Himanshu Gupte; Arun Bamne; John D H Porter; Sheela Rangan
Journal:  BMC Public Health       Date:  2010-05-20       Impact factor: 3.295

7.  Tuberculosis and AIDS stigma among patients who delay seeking care for tuberculosis symptoms.

Authors:  P Pungrassami; A M Kipp; P W Stewart; V Chongsuvivatwong; R P Strauss; A Van Rie
Journal:  Int J Tuberc Lung Dis       Date:  2010-02       Impact factor: 2.373

8.  TB/HIV Co-Infection Care in Conflict-Affected Settings: A Mapping of Health Facilities in the Goma Area, Democratic Republic of Congo.

Authors:  Berthollet Bwira Kaboru; Brenda A Ogwang; Edmond Ntabe Namegabe; Ndemo Mbasa; Deka Kambale Kabunga; Kambale Karafuli
Journal:  Int J Health Policy Manag       Date:  2013-08-29

Review 9.  Global tuberculosis control: lessons learnt and future prospects.

Authors:  Christian Lienhardt; Philippe Glaziou; Mukund Uplekar; Knut Lönnroth; Haileyesus Getahun; Mario Raviglione
Journal:  Nat Rev Microbiol       Date:  2012-05-14       Impact factor: 60.633

10.  Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Authors:  Payam Nahid; Susan E Dorman; Narges Alipanah; Pennan M Barry; Jan L Brozek; Adithya Cattamanchi; Lelia H Chaisson; Richard E Chaisson; Charles L Daley; Malgosia Grzemska; Julie M Higashi; Christine S Ho; Philip C Hopewell; Salmaan A Keshavjee; Christian Lienhardt; Richard Menzies; Cynthia Merrifield; Masahiro Narita; Rick O'Brien; Charles A Peloquin; Ann Raftery; Jussi Saukkonen; H Simon Schaaf; Giovanni Sotgiu; Jeffrey R Starke; Giovanni Battista Migliori; Andrew Vernon
Journal:  Clin Infect Dis       Date:  2016-08-10       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.